No abstract available
MeSH terms
-
Antibodies, Monoclonal, Humanized / therapeutic use*
-
Antineoplastic Agents, Immunological / therapeutic use*
-
Conjunctival Neoplasms / diagnostic imaging
-
Conjunctival Neoplasms / drug therapy*
-
Conjunctival Neoplasms / pathology
-
Humans
-
Injections, Intravenous
-
Male
-
Melanoma / diagnostic imaging
-
Melanoma / drug therapy*
-
Melanoma / pathology
-
Middle Aged
-
Neoplasm Recurrence, Local / diagnostic imaging
-
Neoplasm Recurrence, Local / drug therapy*
-
Neoplasm Recurrence, Local / pathology
-
Programmed Cell Death 1 Receptor
Substances
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents, Immunological
-
Programmed Cell Death 1 Receptor
-
pembrolizumab